In silico SARS-CoV-2 vaccine development for Omicron strain using reverse vaccinology.

Vladimir LiChul LeeDongAhn YooSeoae ChoHeebal Kim

Published in: Genes & genomics (2022)

These results suggest the potential efficacy of our newly developed vaccine construct as a novel vaccine candidate against Omicron strain of the coronavirus.

Keyphrases

sars cov
respiratory syndrome coronavirus
molecular docking
climate change